Pathogenesis of COVID-19 from a cell biologic perspective
暂无分享,去创建一个
[1] Matthew D. Dyer,et al. Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Infection , 2009, Journal of Virology.
[2] W. Zeng,et al. Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features , 2020, Investigative radiology.
[3] J. Sung,et al. Early Enhanced Expression of Interferon-Inducible Protein-10 (CXCL-10) and Other Chemokines Predicts Adverse Outcome in Severe Acute Respiratory Syndrome , 2005, Clinical chemistry.
[4] Gregory P Cosgrove,et al. SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells , 2007, Virology.
[5] Andrew P. Stubbs,et al. Transcriptome Analysis of Infected and Bystander Type 2 Alveolar Epithelial Cells during Influenza A Virus Infection Reveals In Vivo Wnt Pathway Downregulation , 2018, Journal of Virology.
[6] Larissa B. Thackray,et al. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] Jiang Gu,et al. Pathology and Pathogenesis of Severe Acute Respiratory Syndrome , 2007, The American Journal of Pathology.
[8] Jiyuan Zhang,et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.
[9] Yusuke Yamamoto,et al. Distal Airway Stem Cells Yield Alveoli In Vitro and during Lung Regeneration following H1N1 Influenza Infection , 2011, Cell.
[10] Nikolaos M. Nikolaidis,et al. Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection , 2017, Proceedings of the National Academy of Sciences.
[11] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[12] Ralph S. Baric,et al. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.
[13] G. Tipoe,et al. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. , 2001, American journal of respiratory and critical care medicine.
[14] K. L. de Mesy Bentley,et al. Alternative Progenitor Lineages Regenerate the Adult Lung Depleted of Alveolar Epithelial Type 2 Cells , 2017, American journal of respiratory cell and molecular biology.
[15] A. Gruber,et al. Influenza A Viruses Target Type II Pneumocytes in the Human Lung , 2012, The Journal of infectious diseases.
[16] Yoko Ito,et al. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. , 2013, American journal of respiratory cell and molecular biology.
[17] Ralph S. Baric,et al. Severe Acute Respiratory Syndrome Coronavirus Infection of Human Ciliated Airway Epithelia: Role of Ciliated Cells in Viral Spread in the Conducting Airways of the Lungs , 2005, Journal of Virology.
[18] Huaiqiang Sun,et al. High-resolution computed tomography features of 17 cases of coronavirus disease 2019 in Sichuan province, China , 2020, European Respiratory Journal.
[19] Huaiqiang Sun,et al. High-resolution CT features of 17 cases of Corona Virus Disease 2019 in Sichuan province, China , 2020 .
[20] A. Shilatifard,et al. Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis , 2019, American journal of respiratory and critical care medicine.
[21] Yoko Ito,et al. Innate immune response to influenza A virus in differentiated human alveolar type II cells. , 2011, American journal of respiratory cell and molecular biology.
[22] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.